Critically ill patients at extremes of physiology may benefit from mechanical support for heart failure and intensive care practitioners should be knowledgeable about these options. In this article we will discuss the mechanical support for critically ill patients in heart failure. Referral to a specialist centre should be considered early for maximal patient benefit.
MetraMPonikowskiPDicksteinK. Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail2007;9: 684–94.
CostanzoMRMillsRMWynneJ. Characteristics of “Stage D” heart failure: insights from the Acute Decompensated Heart Failure National Registry Longitudinal Module (ADHERE LM). Am Heart J2008;155: 339–47.
4.
StewartSMacIntyreKCapewellSMcMurrayJJ. Heart failure and the aging population: an increasing burden in the 21st century?Heart2003;89: 49–53.
5.
LevyDKenchaiahSLarsonMG. Long-term trends in the incidence of and survival with heart failure. N Engl J Med2002;347: 1397–402.
6.
DarOCowieMR. Acute heart failure in the intensive care unit: epidemiology?Crit Care Med2008; 36(1 Suppl): S3–8.
7.
SomervilleJ. Management of adults with congenital heart disease: an increasing problem. Ann Rev Med1997;48: 283–93.
8.
ValchanovKPArrowsmithJE. The role of venodilators in the perioperative management of heart failure. Eur J Anaesthesiol2012;29: 121–28.
9.
IngwallJS. Energy metabolism in heart failure and remodelling. Cardiovasc Res2009;81: 412–9.
10.
GargRYusufS. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA1995;273: 1450–56.
11.
LechatPPackerMChalonS. Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation1998;98: 1184–91.
12.
BirksEJGeorgeRSHedgerM. Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study. Circulation2011;123: 381–90.
13.
DeBakeyME. Left ventricular bypass pump for cardiac assistance. Clinical experience. Am J Cardiol1971;27: 3–11.
14.
KantrowitzAKrakauerJShermanJLJr. A permanent mechanical auxiliary ventricle: experimental and clinical experience. J Cardiovasc Surg (Torino)1968;9: 1–16.
RanucciMBallottaACastelvecchioS. Perioperative heart failure in coronary surgery and timing of intra-aortic balloon pump insertion?Acta Anaesthesiol Scand2010; 54: 878–84.
17.
ProndzinskyRLemmHSwyterM. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med2010;38: 152–60.
18.
GoldbergRJSamadNAYarzebskiJ. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med1999;340: 1162–68.
19.
ThieleHZeymerUNeumannFJ. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med2012;367: 1287–96.
20.
HungMVuylstekeAValchanovK. Extracorporeal membrane oxygenation: coming to an ICU near you. JICS2012;13: 31–38.
21.
ThomasHLDronavalliVBParameshwarJ. Incidence and outcome of Levitronix CentriMag support as rescue therapy for early cardiac allograft failure: a United Kingdom national study. Eur J Cardiothorac Surg2011;40: 1348–54.
22.
JohnRLongJWMasseyHT. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg2011;141: 932–39.
23.
KarBAdkinsLECivitelloAB. Clinical experience with the TandemHeart percutaneous ventricular assist device. Tex Heart Inst J2006;33: 111–15.
24.
BennettMTViraniSABoweringJ. The use of the Impella RD as a bridge to recovery for right ventricular dysfunction after cardiac transplantation. Innovations (Phila)2010;5: 369–71.
25.
RoseEAMoskowitzAJPackerM. The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg1999;67: 723–30.
26.
RoseEAGelijnsACMoskowitzAJ. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med2001;345: 1435–43.
27.
KatoTSChokshiASinghP. Effects of continuous-flow versus pulsatile-flow left ventricular assist devices on myocardial unloading and remodeling. Circ Heart Fail2011;4: 546–53.
28.
SlaughterMSRogersJGMilanoCA. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med2009;361: 2241–51.
29.
FrazierOHRoseEAOzMC. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg2001;122: 1186–95.
SlaughterMSSobieskiMAMartinM. Home discharge experience with the Thoratec TLC-II portable driver. ASAIO J2007;53: 132–35.
32.
El-BanayosyAArusogluLKiznerL. Novacor left ventricular assist system versus Heartmate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: a prospective study. J Thorac Cardiovasc Surg2000;119: 581–87.
33.
El-BanayosyADengMLoisanceDY. The European experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant: a retrospective multi-centre study. Eur J Cardiothorac Surg1999;15: 835–41.
34.
MillerLWPaganiFDRussellSD. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med2007;357: 885–96.
35.
CrowSJohnRBoyleAShumwayS. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg2009;137: 208–15.
36.
JaroszewskiDEAndersonEMPierceCNArabiaFA. The SynCardia freedom driver: a portable driver for discharge home with the total artificial heart. J Heart Lung Transplant2011;30: 844–45.
37.
ValchanovKParameshwarJ. Inpatient management of advanced heart failure. Cont Educ Anaesth Crti Care Pain2008;8: 167–71.
